Phlexglobal is a specialist provider of technology-enabled document management solutions and other support services to the global clinical research market.
Established in 1997, its Trial Master File ("TMF") software and services support the administrative and operational aspects of the pharmaceutical clinical trial process. A 'TMF' is required by law and demonstrates compliance with regulatory standards for the conduct of a clinical trial.
Bridgepoint's investment will support Phlexglobal's existing management to deliver the geographical and strategic growth that they are seeking to achieve, including an increasing emphasis on technology led electronic TMF solutions.
In December 2016, Phlexglobal was acquired by Vitruvian Partners.
To learn more about the company, visit www.phlexglobal.com